Your Search Returned 23 tagged news reports
The U.S. health regulator has approved the generic versions of Eli Lilly & Company's Cymbalta, a drug to treat depression, paving the way for various Indian pharmaceutical companies to launch their products in the U.S. market...Aurobindo Pharma, Dr.
US market D rug major Lupin said on Monday it has launched a generic version of Japan-headquartered Eisai Inc's Aciphex delayed-release tablets, used to treat gastroesophageal reflux disease, in the US market. The company's US-based subsidiary Lupin
D rug major Lupin said on Tuesday it has received US health regulator's approval to market additional strengths of Antara capsules, a cholesterol lowering drug, in the American market. Lupin Ltd said in a statement. "Lupin Pharmaceuticals Inc, the
Drug maker Lupin Thursday said it has launched the generic version of Allergan Inc's Zymaxid Ophthalmic Solution in the US market with 180 days of marketing exclusivity. Lupin Pharmaceuticals Inc, the company's US subsidiary, launched its generic
Pharma major Lupin has received the US health regulator's approval to market a generic version of Warner Chilcott Company's 'Ovcon 35' tablets, an oral contraceptive, in the American market, the company said Friday. Lupin's US subsidiary Lupin
Pharmaceutical major Lupin has signed an agreement with US-based Onset Dermatologics under which it will market the latter's skin disease treatment medicine Locoid Lotion in the American market. Lupin's US subsidiary, Lupin Pharmaceuticals Inc, has
Drug maker Lupin Friday said it has received the US health regulator's approval to market a generic version of Sanofi Aventis' Rifadin capsules, used to treat tuberculosis, in the American market. Rifampin Capsules in 150 mg and 300 mg strengths,
Alinia (nitazoxanide) is used for the treatment of diarrhoea caused by Cryptosporidium and Giardia, in patients one year of age and older, and is approved by the US Food and Drug Administration, Lupin said. Cryptosporidium and Giardia are the two
Ranexa Extended-release tablets 500mg and 1000mg strengths and as such will be entitled to 180 days of marketing exclusivity," it said. Ranolazine Extended-release tablets are indicated for treatment of chronic angina.
New Delhi, January 22, 2013 Drug firm Lupin on Tuesday said it has received final approval from the US health regulator to sell its generic oral contraceptive Levonorgestrel and Ethinyl Estradiol tablets in the American market. Levonorgestrel and